Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...
CD19-targeted CAR T-cell therapy shows a 65% response rate in Richter transformation, with median progression-free survival of 8 months and overall survival of 14.4 months. Early response and age are ...
For the first time, a stem cell model has produced a structure resembling an early human embryo with a yolk-sac-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results